Medindia

X

Amerigroup to Present at Goldman Sachs 32nd Annual Global Healthcare Conference

Wednesday, June 1, 2011 General News J E 4
Advertisement

VIRGINIA BEACH, Va., June 1, 2011 /PRNewswire-FirstCall/ -- Amerigroup Corporation (NYSE: AGP) today announced that it will participate in the Goldman Sachs 32nd Annual Global Healthcare Conference on June 9, 2011 in Rancho Palos Verdes, California.

A live webcast of the Company's presentation, which begins Thursday, June 9 at 1:00 p.m. Eastern Time, can be accessed on Amerigroup's web site, www.amerigroupcorp.com, on the investors' page.  A replay of the webcast will be available for 30 days after the presentation and can be accessed at the same web address.

About Amerigroup Corporation

Amerigroup, a Fortune 500 Company, coordinates services for individuals in publicly funded health care programs. Serving approximately 2 million members in 11 states nationwide, Amerigroup accepts all eligible people regardless of age, sex, race or disability. The Company's product offerings do not utilize any individual underwriting nor deny coverage due to pre-existing medical conditions. Amerigroup is dedicated to offering real solutions that improve health care access and quality for its members, while proactively working to reduce the overall cost of care to taxpayers. Click here for more information about Amerigroup Corporation.

CONTACTS:  

Investors:  Julie Loftus TrudellAmerigroup CorporationSenior Vice President, Investor Relations(757) 321-3597jtrudell@amerigroupcorp.com

News Media: Maureen C. McDonnellAmerigroup Corporation Vice President, External Communications(757) 473-2731mmcdonn@amerigroupcorp.com  

SOURCE Amerigroup Corporation

Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
MirixaEdge(SM) to be Licensed by One Source Pharma...
S
Argos Therapeutics' Arcelis™ Immunotherapy for the...